Literature DB >> 21056708

EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation.

Agnieszka Arthur1, Andrew Zannettino, Romana Panagopoulos, Simon A Koblar, Natalie A Sims, Con Stylianou, Koichi Matsuo, Stan Gronthos.   

Abstract

Bone marrow derived mesenchymal stem/stromal cells (MSC) contribute to skeletal tissue formation and the regulation of haematopoiesis. The Eph/ephrin family of receptor tyrosine kinases is potentially important in the maintenance of the stem cell niche within neural, intestinal and dental tissues and has recently been shown to play a role in regulating bone homeostasis. However, the contribution of EphB/ephrin-B molecules in human MSC function remains to be determined. In the present study, EphB and ephrin-B molecules were expressed by ex vivo expanded human MSC populations and within human bone marrow trephine samples. To elucidate the contribution of EphB/ephrin-B molecules in MSC recruitment, we performed functional spreading and migration assays and showed that reverse ephrin-B signalling inhibited MSC attachment and spreading by activating Src-, PI3Kinase- and JNK-dependent signalling pathways. In contrast, forward EphB2 signalling promoted MSC migration by activating the Src kinase- and Abl-dependent signalling pathways. Furthermore, activation of ephrin-B1 and/or ephrin-B2 molecules expressed by MSC was found to increase osteogenic differentiation, while ephrin-B1 activation promoted chondrogenic differentiation. These observations suggest that EphB/ephrin-B interactions may mediate the recruitment, migration and differentiation of MSC during bone repair.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056708     DOI: 10.1016/j.bone.2010.10.180

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  46 in total

1.  Eph/ephrin interactions modulate muscle satellite cell motility and patterning.

Authors:  Danny A Stark; Rowan M Karvas; Ashley L Siegel; D D W Cornelison
Journal:  Development       Date:  2011-11-09       Impact factor: 6.868

Review 2.  The role of Eph/ephrin molecules in stromal–hematopoietic interactions.

Authors:  Thao M Nguyen; Agnieszka Arthur; Stan Gronthos
Journal:  Int J Hematol       Date:  2016-02       Impact factor: 2.490

3.  EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

Authors:  Thao M Nguyen; Agnes Arthur; John D Hayball; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2013-06-29       Impact factor: 3.272

4.  Stimulation of EphB2/ephrin-B1 signalling by tumour necrosis factor alpha in human dental pulp stem cells.

Authors:  Lifang Zhu; Waruna Lakmal Dissanayaka; David William Green; Chengfei Zhang
Journal:  Cell Prolif       Date:  2015-02-03       Impact factor: 6.831

Review 5.  Regulation of cell differentiation by Eph receptor and ephrin signaling.

Authors:  David G Wilkinson
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

6.  Early molecular responses of bone to estrogen deficiency induced by ovariectomy in rats.

Authors:  Xu Yan; Tian-Wen Ye
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 7.  Ephrin ligands and Eph receptors contribution to hematopoiesis.

Authors:  Giovanna Tosato
Journal:  Cell Mol Life Sci       Date:  2017-06-06       Impact factor: 9.261

Review 8.  Intercellular cross-talk among bone cells: new factors and pathways.

Authors:  Natalie A Sims; Nicole C Walsh
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

Review 9.  Flow-induced mechanotransduction in skeletal cells.

Authors:  Roberta Alfieri; Massimo Vassalli; Federica Viti
Journal:  Biophys Rev       Date:  2019-09-16

10.  Genistein attenuates glucocorticoid-induced bone deleterious effects through regulation Eph/ephrin expression in aged mice.

Authors:  Yuan Cheng; Wei-Lin Wang; Jun-Jun Liang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.